Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes.

Labiano S, Meléndez-Rodríguez F, Palazón A, Teijeira Á, Garasa S, Etxeberria I, Aznar MÁ, Sánchez-Paulete AR, Azpilikueta A, Bolaños E, Molina C, de la Fuente H, Maiso P, Sánchez-Madrid F, de Landázuri MO, Aragonés J, Melero I.

Oncoimmunology. 2017 Jan 19;6(4):e1283468. doi: 10.1080/2162402X.2017.1283468. eCollection 2017.

2.

The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.

Palazón A, Martínez-Forero I, Teijeira A, Morales-Kastresana A, Alfaro C, Sanmamed MF, Perez-Gracia JL, Peñuelas I, Hervás-Stubbs S, Rouzaut A, de Landázuri MO, Jure-Kunkel M, Aragonés J, Melero I.

Cancer Discov. 2012 Jul;2(7):608-23. doi: 10.1158/2159-8290.CD-11-0314. Epub 2012 Jun 19.

3.

Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival.

Conde E, Alegre L, Blanco-Sánchez I, Sáenz-Morales D, Aguado-Fraile E, Ponte B, Ramos E, Sáiz A, Jiménez C, Ordoñez A, López-Cabrera M, del Peso L, de Landázuri MO, Liaño F, Selgas R, Sanchez-Tomero JA, García-Bermejo ML.

PLoS One. 2012;7(3):e33258. doi: 10.1371/journal.pone.0033258. Epub 2012 Mar 14.

4.

Molecular pathways: hypoxia response in immune cells fighting or promoting cancer.

Palazón A, Aragonés J, Morales-Kastresana A, de Landázuri MO, Melero I.

Clin Cancer Res. 2012 Mar 1;18(5):1207-13. doi: 10.1158/1078-0432.CCR-11-1591. Epub 2011 Dec 28. Review.

5.

Multiple cis-acting elements regulate the expression of the early T cell activation antigen CD69.

Castellanos Mdel C, López-Giral S, López-Cabrera M, de Landázuri MO.

Eur J Immunol. 2002 Nov;32(11):3108-17.

6.

Phosphodiesterases 4D and 7A splice variants in the response of HUVEC cells to TNF-alpha(1).

Miró X, Casacuberta JM, Gutiérrez-López MD, de Landázuri MO, Puigdomènech P.

Biochem Biophys Res Commun. 2000 Aug 2;274(2):415-21.

PMID:
10913353
7.

Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1.

Vidal F, Aragonés J, Alfranca A, de Landázuri MO.

Blood. 2000 Jun 1;95(11):3387-95.

PMID:
10828020
8.

Memory B lymphocytes from secondary lymphoid organs interact with E-selectin through a novel glycoprotein ligand.

Montoya MC, Holtmann K, Snapp KR, Borges E, Sánchez-Madrid F, Luscinskas FW, Kansas G, Vestweber D, de Landázuri MO.

J Clin Invest. 1999 May;103(9):1317-27.

9.

The chemokine SDF-1alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes.

Vicente-Manzanares M, Montoya MC, Mellado M, Frade JM, del Pozo MA, Nieto M, de Landazuri MO, Martínez-A C, Sánchez-Madrid F.

Eur J Immunol. 1998 Jul;28(7):2197-207.

10.

Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions.

Yáñez-Mó M, Alfranca A, Cabañas C, Marazuela M, Tejedor R, Ursa MA, Ashman LK, de Landázuri MO, Sánchez-Madrid F.

J Cell Biol. 1998 May 4;141(3):791-804.

11.

Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1.

Castellanos MC, Muñoz C, Montoya MC, Lara-Pezzi E, López-Cabrera M, de Landázuri MO.

J Immunol. 1997 Dec 1;159(11):5463-73.

PMID:
9580241
12.

Reduced intracellular oxidative metabolism promotes firm adhesion of human polymorphonuclear leukocytes to vascular endothelium under flow conditions.

Montoya MC, Luscinskas FW, del Pozo MA, Aragonés J, de Landázuri MO.

Eur J Immunol. 1997 Aug;27(8):1942-51.

PMID:
9295030
13.

Up-regulated beta1-integrin expression in autoimmune thyroid disorders.

Marazuela M, De Landázuri MO, Larrañaga E, Sánchez-Madrid F.

Clin Exp Immunol. 1997 Jul;109(1):107-15.

15.

Transcriptional up-regulation of intracellular adhesion molecule-1 in human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1.

Muñoz C, Castellanos MC, Alfranca A, Vara A, Esteban MA, Redondo JM, de Landázuri MO.

J Immunol. 1996 Oct 15;157(8):3587-97.

PMID:
8871659
16.

Dithiocarbamates trigger differentiation and induction of CD11c gene through AP-1 in the myeloid lineage.

Aragonés J, López-Rodríguez C, Corbí A, del Arco PG, López-Cabrera M, de Landázuri MO, Redondo JM.

J Biol Chem. 1996 May 3;271(18):10924-31.

17.

Immunology research.

De Landázuri MO.

Clin Sci (Lond). 1996 Mar;90(3):148-53. No abstract available.

PMID:
8777814
18.

Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders.

Marazuela M, Sánchez-Madrid F, Acevedo A, Larrañaga E, de Landázuri MO.

Clin Exp Immunol. 1995 Nov;102(2):328-34.

19.

B-cell homotypic adhesion through exon-A restricted epitopes of CD45 involves LFA-1/ICAM-1, ICAM-3 interactions, and induces coclustering of CD45 and LFA-1.

Zapata JM, Campanero MR, Marazuela M, Sánchez-Madrid F, de Landázuri MO.

Blood. 1995 Sep 1;86(5):1861-72.

PMID:
7544645
20.
21.

Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.

Marazuela M, Postigo AA, Acevedo A, Díaz-González F, Sanchez-Madrid F, de Landázuri MO.

Eur J Immunol. 1994 Oct;24(10):2483-90.

PMID:
7523142
22.

Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages.

Zapata JM, Pulido R, Acevedo A, Sánchez-Madrid F, de Landázuri MO.

J Immunol. 1994 Apr 15;152(8):3852-61.

PMID:
8144955
23.

Alpha 4 beta 7 integrin mediates B cell binding to fibronectin and vascular cell adhesion molecule-1. Expression and function of alpha 4 integrins on human B lymphocytes.

Postigo AA, Sánchez-Mateos P, Lazarovits AI, Sánchez-Madrid F, de Landázuri MO.

J Immunol. 1993 Sep 1;151(5):2471-83.

PMID:
7689608
24.
25.

VLA family in rheumatoid arthritis: evidence for in vivo regulated adhesion of synovial fluid T cells to fibronectin through VLA-5 integrin.

García-Vicuña R, Humbría A, Postigo AA, López-Elzaurdia C, de Landázuri MO, Sánchez-Madrid F, Laffón A.

Clin Exp Immunol. 1992 Jun;88(3):435-41.

26.

Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

Postigo AA, Garcia-Vicuña R, Diaz-Gonzalez F, Arroyo AG, De Landázuri MO, Chi-Rosso G, Lobb RR, Laffon A, Sánchez-Madrid F.

J Clin Invest. 1992 May;89(5):1445-52.

27.

Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1.

Tugores A, Alonso MA, Sánchez-Madrid F, de Landázuri MO.

J Immunol. 1992 Apr 1;148(7):2300-6.

PMID:
1545132
28.

Functional analysis of peripheral blood lymphocytes isolated from patients with chronic hepatitis type B.

García-Monzón C, Moreno-Otero R, García-Buey L, López-Botet M, De Landázuri MO, Sánchez-Madrid F.

Dig Dis Sci. 1992 Jan;37(1):73-8.

PMID:
1728533
30.

Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils.

Alvarez V, Pulido R, Campanero MR, Paraiso V, de Landázuri MO, Sánchez-Madrid F.

Kidney Int. 1991 Nov;40(5):899-905.

31.

Differential expression of VLA-4 integrin by resident and peripheral blood B lymphocytes. Acquisition of functionally active alpha 4 beta 1-fibronectin receptors upon B cell activation.

Postigo AA, Pulido R, Campanero MR, Acevedo A, García-Pardo A, Corbi AL, Sanchez-Madrid F, De Landazuri MO.

Eur J Immunol. 1991 Oct;21(10):2437-45.

PMID:
1833203
32.

Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

Laffón A, García-Vicuña R, Humbría A, Postigo AA, Corbí AL, de Landázuri MO, Sánchez-Madrid F.

J Clin Invest. 1991 Aug;88(2):546-52.

33.

Phosphorylation-dephosphorylation of the CD6 glycoprotein renders two isoforms of 130 and 105 kilodaltons. Effect of serum and protein kinase C activators.

Cardenas L, Carrera AC, Yague E, Pulido R, Sánchez-Madrid F, de Landázuri MO.

J Immunol. 1990 Sep 1;145(5):1450-5.

PMID:
2384666
34.

An alternative leukocyte homotypic adhesion mechanism, LFA-1/ICAM-1-independent, triggered through the human VLA-4 integrin.

Campanero MR, Pulido R, Ursa MA, Rodríguez-Moya M, de Landázuri MO, Sánchez-Madrid F.

J Cell Biol. 1990 Jun;110(6):2157-65.

35.

A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.

Aramburu J, Balboa MA, Ramírez A, Silva A, Acevedo A, Sánchez-Madrid F, De Landázuri MO, López-Botet M.

J Immunol. 1990 Apr 15;144(8):3238-47.

PMID:
1691231
36.

Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis.

García-Monzón C, Moreno-Otero R, Pajares JM, García-Sánchez A, López-Botet M, de Landázuri MO, Sánchez-Madrid F.

Gastroenterology. 1990 Apr;98(4):1029-35.

PMID:
2138103
37.

Activators of protein kinase C up-regulate the cell surface expression of CD2 and CD5 T cell glycoproteins.

Carrera AC, Cárdenas L, Tugores A, Alonso M, Sánchez-Madrid F, de Landázuri MO.

J Biol Chem. 1989 Sep 15;264(26):15650-5.

38.

Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies.

Sánchez-Mateos P, Cebrián M, Acevedo A, López-Botet M, De Landázuri MO, Sánchez-Madrid F.

Immunology. 1989 Sep;68(1):72-9.

39.

Expression and function of AIM, an activation inducer molecule of human lymphocytes, is dependent on the activation of protein kinase C.

Cebrián M, Redondo JM, López-Rivas A, Rodríguez-Tarduchy G, De Landázuri MO, Sánchez-Madrid F.

Eur J Immunol. 1989 May;19(5):809-15.

PMID:
2786811
40.

Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.

Cebrián M, Yagüe E, Rincón M, López-Botet M, de Landázuri MO, Sánchez-Madrid F.

J Exp Med. 1988 Nov 1;168(5):1621-37.

41.

Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.

Rincón M, Tugores A, López-Rivas A, Silva A, Alonso M, De Landázuri MO, López-Botet M.

Eur J Immunol. 1988 Nov;18(11):1791-6.

PMID:
2849551
42.

Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies.

Carrera AC, Rincón M, Sánchez-Madrid F, López-Botet M, de Landaźuri MO.

J Immunol. 1988 Sep 15;141(6):1919-24.

PMID:
2459196
43.

CD2 is involved in regulating cyclic AMP levels in T cells.

Carrera AC, Rincón M, De Landázuri MO, López-Botet M.

Eur J Immunol. 1988 Jun;18(6):961-4.

PMID:
2898370
44.

Comparative biochemical and tissue distribution study of four distinct CD45 antigen specificities.

Pulido R, Cebrián M, Acevedo A, de Landázuri MO, Sánchez-Madrid F.

J Immunol. 1988 Jun 1;140(11):3851-7.

PMID:
2453558
45.

An in vivo functional immune system lacking polyclonal T-cell surface expression of the CD3/Ti(WT31) complex.

Regueiro JR, López-Botet M, De Landazuri MO, Alcami J, Corell A, Martín-Villa JM, Vicario JL, Arnaiz-Villena A.

Scand J Immunol. 1987 Dec;26(6):699-708.

PMID:
2962274
46.
47.

Defective interleukin 2 receptor expression is associated with the T cell disfunction subsequent to bone marrow transplantation.

López-Botet M, De Landazuri MO, Izquierdo M, Ramirez A, Cámara R, Fernández-Rañada J.

Eur J Immunol. 1987 Aug;17(8):1167-74.

PMID:
3113980
48.

Involvement of the CD4 molecule in a post-activation event on T cell proliferation.

Carrera AC, Sanchez-Madrid F, Lopez-Botet M, Bernabeu C, De Landazuri MO.

Eur J Immunol. 1987 Feb;17(2):179-86.

PMID:
3104060
49.

Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.

Cebrián M, Yagüe E, de Landázuri MO, Rodíguez-Moya M, Fresno M, Pezzi N, Llamazares S, Sánchez-Madrid F.

J Immunol. 1987 Jan 15;138(2):484-90.

PMID:
2432126
50.

VLA-3: a novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization.

Sánchez-Madrid F, De Landázuri MO, Morago G, Cebrián M, Acevedo A, Bernabeu C.

Eur J Immunol. 1986 Nov;16(11):1343-9.

PMID:
2430809

Supplemental Content

Loading ...
Support Center